Symptom Prevalence
Primary UC Symptoms
Self-reported prevalence across the full patient cohort (n = 15,600).
76%
Report Diarrhea
n = 9,730
69%
Experience Urgency
n = 8,800
64%
Abdominal Pain
n = 8,390
58%
Rectal Bleeding
n = 7,340
51%
Chronic Fatigue
n = 7,130
38%
Nausea
n = 4,890
33%
Joint Pain
n = 4,200
79%
Stress → Symptom Spike
Within 48 hours onset
Medication Outcomes
Community-Reported Remission Trends
Patient-reported positive response rates for 9 tracked medications. These are community-reported trends, not clinical endpoints.
Entyvio (Vedolizumab)
Biologic · Anti-integrin
78%
Highest community-reported response rate among tracked biologics.
Stelara (Ustekinumab)
Biologic · IL-12/23
72%
Strong positive sentiment, particularly for patients with prior biologic failure.
Rinvoq (Upadacitinib)
Small molecule · JAK inhibitor
70%
Rapid onset noted by community; growing adoption in recent reports.
Humira (Adalimumab)
Biologic · Anti-TNF
62%
Widely used; some reports of secondary loss of response over time.
Remicade (Infliximab)
Biologic · Anti-TNF
61%
IV infusion format; often used in moderate-to-severe presentations.
Skyrizi (Risankizumab)
Biologic · Anti-IL-23
68%
Newer agent with emerging positive community experience.
Xeljanz (Tofacitinib)
Small molecule · JAK inhibitor
57%
Oral convenience noted; community discusses safety monitoring requirements.
Mesalamine (5-ASA)
Aminosalicylate · First-line
54%
Standard first-line therapy; positive rates higher for mild-to-moderate disease.
Prednisone
Corticosteroid · Bridge therapy
49%
Commonly used for flare induction; mixed long-term sentiment due to side effects.
Food Tolerability
Community Food Safety Ratings
Patient-scored food tolerability across 22+ items. Scores represent percentage of community reporting the food as safe or well-tolerated.
78%
Banana
Safe
74%
White Rice
Safe
71%
Plain Chicken
Safe
69%
Cooked Carrots
Safe
68%
Plain Toast
Safe
65%
Oatmeal
Safe
47%
Yogurt
Moderate
41%
Eggs
Moderate
22%
Raw Vegetables
Avoid
18%
Spicy Foods
Avoid
16%
Fried Foods
Avoid
14%
Alcohol
Avoid
Data Disclaimer: All figures represent aggregated community-reported data and AI-analyzed patient experiences. This dataset is observational and does not constitute clinical evidence or medical guidance. Individual responses to foods and medications vary significantly. Always consult your gastroenterologist before making any changes to your diet or treatment plan.